Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Gross Margin: 2009-2024

Historic Gross Margin for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to 55.05%.

  • Cumberland Pharmaceuticals' Gross Margin fell 507.00% to 46.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 58.54%, marking a year-over-year increase of 628.00%. This contributed to the annual value of 55.05% for FY2024, which is 170.00% up from last year.
  • Cumberland Pharmaceuticals' Gross Margin amounted to 55.05% in FY2024, which was up 3.18% from 53.35% recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Gross Margin registered a high of 60.56% during FY2020, and its lowest value of 53.35% during FY2023.
  • Its 3-year average for Gross Margin is 56.25%, with a median of 55.05% in 2024.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Gross Margin soared by 499bps in 2020, and later slumped by 699bps in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Gross Margin (Yearly) stood at 60.56% in 2020, then plummeted by 229bps to 58.27% in 2021, then surged by 207bps to 60.34% in 2022, then tumbled by 699bps to 53.35% in 2023, then skyrocketed by 170bps to 55.05% in 2024.